What are the future directions in PCSK9 Inhibitor research?
Future research aims to further elucidate the long-term safety and efficacy of PCSK9 inhibitors, explore potential benefits beyond cholesterol lowering, and develop oral formulations to improve patient adherence. Additionally, ongoing studies are examining their role in primary prevention and in conditions beyond hypercholesterolemia, such as atherosclerosis.
